Anti-tumour necrosis factor α antibodies and circulating lymphocyte phenotypes in inflammatory bowel disease

•CD70+ receptor is a marker of T cell activation during inflammatory bowel disease.•CD70+ T cells was significantly reduced by treatment with anti-TNFα antibodies.•CD3+ T cells were increased in anti-TNFα treated compared to untreated patients.•Relation between the drug behaviour and the lymphocytes...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International immunopharmacology 2021-11, Vol.100, p.108081-108081, Article 108081
Hauptverfasser: Defendenti, Caterina, Tarkowski, Maciej, Borille, Simona, Cassinotti, Andrea, Massari, Alessandro, Birindelli, Sarah, Riva, Agostino, Ardizzone, Sandro, Panteghini, Mauro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!